PVNNF yields 2000000.00% · MRK yields 2.76%● Live data
📍 PVNNF pulled ahead of the other in Year 1
Combined, PVNNF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PVNNF + MRK for your $10,000?
P.V. Nano Cell Ltd. engages in developing, manufacturing, marketing, and commercializing conductive inks for digital inkjet conductive printing applications. It develops the Sicrys family of single crystal nano-metric conductive inks; and silver-based Sicrys inks for printed electronics (PE) applications, including photovoltaic devices, printed passive components, circuit boards, mobile phone antennas, 3D printed electronic devices, radio-frequency identification chips, sensors and touchscreens, and other digital PE, as well as printing of windshields in automotive applications. The company also provides copper-based nano-metric inks for mass-production of PE. In addition, it manufactures printing machines, which offer solutions for inkjet print-quality technologies; and provides gold, resistor, and dielectric inks. The company operates in Israel, the United States, Spain, Germany, Holland, Austria, and internationally. P.V. Nano Cell Ltd. was incorporated in 2009 and is headquartered in Migdal HaEmek, Israel.
Full PVNNF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.